To distinguish between mosaic NF2 and schwannomatosis, it is necessary to perform NF2 mutation testing in more than one tumour from a given patient who does not carry a germline mutation in SMARCB1 or LZTR1 as determined by blood cell analysis. Here, SMARCB1 is linked to schwannomatosis.